Planning prospect of Hunan Wang Jiu Pharmaceutical Co., Ltd.

According to the company's five-year development plan, within three years, it will invest 300 million yuan to acquire or newly establish a holding subsidiary of 1 1 in cities and counties of Hunan Province, covering the distribution network of drugs and medical devices in urban and rural areas of Hunan Province; In two years, the sales exceeded 65.438+0.5 billion yuan, and in three years, it reached the scale of more than 3 billion yuan, building a regional modern logistics headquarters enterprise in Hunan Province; At the same time, Shanghai Pharmaceutical will give full play to its scientific research advantages in biological products, make use of existing exclusive varieties and approved varieties, and plan to invest 654.38+0.5 billion yuan to build a standardized, information-based, automated, comprehensive and fast pharmaceutical industrial production park.

The company's superior (headquarters) Shanghai Pharmaceutical Group Co., Ltd. is a national pharmaceutical industry group headquartered in Shanghai and the only A+H large-scale pharmaceutical listed company in China. The company's main business covers the whole industrial chain of pharmaceutical R&D, manufacturing, distribution and retail. In 20 12, the sales revenue reached 80 billion yuan, ranking first in the fixed assets of the national pharmaceutical industry, second in the sales scale, and among the top 500 Chinese enterprises. The Group owns Academia Sinica, 3 national technical centers and 14 provincial (city) technical centers, and has established long-term strategic cooperative relations with more than 80 famous scientific research institutes such as Institute of Materia Medica, Chinese Academy of Sciences, successfully researched and developed 277 national new drugs, and applied for more than 10 national "major scientific and technological projects". It owns more than 20 well-known brands such as Xinyi, Schleswig and Longhu and well-known trademarks in China, and has established important cooperative partnerships with 36 of the world's top 50 pharmaceutical multinational companies. More than 20 products have been sold in cardiovascular and cerebrovascular diseases, anti-infection, digestive system, nervous system, anti-tumor and other fields.

Hunan Shangyu Wang Jiu Pharmaceutical Co., Ltd. undertook all relevant business qualifications, marketing network and management team of the former Wang Jiu Pharmaceutical Company. The sales network has covered all cities in Hunan, including 63 hospitals with dimethyl ether and above, 9 top-class hospitals and 4 ministerial hospitals. The coverage rate of military hospitals is over 65%. The existing companies and terminals all reflect that our products are reliable in quality and considerate in service, especially narcotic drugs and psychotropic drugs, with complete varieties and fast delivery.

The company is firmly market-oriented, science and technology-based, honesty as the criterion, brand as the core, and the purpose of meeting users' needs, serving customers and contributing to society. Adhering to the principle of mutual benefit and win-win, the company is willing to create a better future with colleagues from all walks of life.